REVG Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
REVG is not a good buy right now. The technical setup is still bearish (negative and expanding MACD, price sitting just below key support), insiders are aggressively selling, and pattern-based stats point to further near-term downside. With no proprietary buy signals today and no positive news catalysts, the risk/reward does not fit an impatient buyer looking to enter immediately.
Trend/strength: Bearish to weakening. The MACD histogram is -0.682 and negatively expanding, which typically signals downside momentum is still building rather than stabilizing. RSI(6) at ~30.2 is near oversold territory, which can produce short bounces, but by itself does not confirm a durable reversal. Levels: Current price 64.69 is below the pivot (67.017) and essentially sitting on/just under S1 (64.853). If S1 fails to hold, the next notable support is S2 at 63.516. Upside resistance is heavy: first the pivot (67.017) then R1 (69.181). Moving averages are converging, which often precedes a bigger move; combined with bearish MACD, the bias is down. Near-term probability: Similar-pattern analysis suggests a 70% chance of additional declines (-1.62% next day, -2.65% next week), reinforcing that the path of least resistance remains lower.
holds.
hints at some near-term bullish positioning.
No recent news catalysts to justify stepping in ahead of a clear technical reversal.
Latest quarter (2025/Q4): Revenue rose to $664.4M (+11.12% YoY), showing continued top-line growth. However, profitability deteriorated: net income fell to $28.9M (-30.70% YoY) and EPS dropped to $0.58 (-26.58% YoY). A bright spot is gross margin expansion to 15.44% (+17.86% YoY), but the bottom-line decline suggests higher costs, mix, or other below-the-line pressures are still weighing on earnings.
No analyst rating trend or price target changes were provided in the data, so a confirmed Wall Street pros/cons consensus cannot be stated here. Based strictly on the provided fundamentals/technicals: Pros would center on revenue growth and improving gross margin; cons would focus on declining EPS/net income, bearish momentum, and heavy insider selling.
